What new Dupilumab data suggest about long-term immune control in allergic disease at Regeneron Pharmaceuticals
Ryerson Holding (NYSE: RYI) finalises Olympic Steel acquisition as North American metals consolidation accelerates
Read More 4 minute read Pharma Industry News Why AI–CRDMO partnerships are gaining ground in early-stage drug discovery pipelines AI–CRDMO collaborations are changing how drugs are discovered and validated. See why they’re attracting biotech startups and pharma innovators alike. byPallavi MadhirajuAugust 7, 2025